These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1314200)

  • 1. A novel tumor-associated protein: clinical significance of serum levels in various clinical conditions with special reference to gynecological malignant diseases.
    Nakai M; Kawauchi H; Atsumi M; Majima T; Ishikawa M
    Eur J Obstet Gynecol Reprod Biol; 1992 Jan; 43(2):143-7. PubMed ID: 1314200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
    Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
    Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum levels of a immunosuppressive acidic protein in patients with gynecological cancer (author's transl)].
    Suzuki H; Miyoshi T; Sasaki H; Yoshida T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):513-8. PubMed ID: 6785990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
    Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer developing in the ovarian remnant syndrome. A case report and literature review.
    Narayansingh G; Cumming G; Parkin D; Miller I
    Aust N Z J Obstet Gynaecol; 2000 May; 40(2):221-3. PubMed ID: 10925917
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
    Scambia G; Benedetti Panici P; Perrone L; Sonsini C; Giannelli S; Gallo A; Natali PG; Mancuso S
    Br J Cancer; 1990 Jul; 62(1):147-51. PubMed ID: 2167724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen.
    Inaba N; Negishi Y; Fukasawa I; Okajima Y; Ota Y; Tanaka K; Matsui H; Iwasaki H; Sudo H; Tanaka N
    Tumour Biol; 1995; 16(6):345-52. PubMed ID: 7569681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinogen degradation products in gynecologic neoplasms].
    Tatra G; Breitenecker G; Karsai I
    Fortschr Med; 1976 May; 94(13):752-4. PubMed ID: 955534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of circulating tumor necrosis factor-alpha in patients with gynecological malignancies.
    De Jaco P; Asselain B; Orlandi C; Fridman WH; Teillaud JL
    Int J Cancer; 1991 May; 48(3):375-8. PubMed ID: 2040531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transient form of serum albumin in gynecologic cancer].
    Rybalka AN; Bagdasar'ian SN; Garina TN; Karpilenko TM; Kasymova GA
    Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 serum levels in patients with gynecological tumors.
    Scambia G; Testa U; Panici PB; Martucci R; Foti E; Petrini M; Amoroso M; Masciullo V; Peschle C; Mancuso S
    Int J Cancer; 1994 May; 57(3):318-23. PubMed ID: 8168990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of CA125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review.
    Ghaemmaghami F; Karimi Zarchi M; Hamedi B
    Arch Gynecol Obstet; 2007 Nov; 276(5):559-61. PubMed ID: 17497163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum Dkk-3 in patients with gynecological cancer.
    Jiang T; Huang L; Wang S; Zhang S
    J Obstet Gynaecol Res; 2010 Aug; 36(4):769-73. PubMed ID: 20666943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S; Mesa-Tejada R; Husami N; Bennett S; Richart RM; Fenogolio CM
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterus didelphys with cervical agenesis associated with adenomyosis, a leiomyoma and ovarian endometriosis. A case report.
    Yang CC; Tseng JY; Chen P; Wang PH
    J Reprod Med; 2002 Nov; 47(11):936-8. PubMed ID: 12497685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated serum globulin determined in patients with cervical, endometrial and ovarian cancer.
    Altarac S
    Acta Med Croatica; 1993; 47(1):19-22. PubMed ID: 7693081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.